A Study to Evaluate the Efficacy and Safety of Ensifentrine for 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Clinical trial NCT05743075 · COMPLETED
Trial details
- NCT number
- NCT05743075
- Sponsor
- Nuance Pharma (shanghai) Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-10
- Primary completion
- 2024-12-06
- Enrollment
- 526
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.